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Stroke is without any doubt among the top reasons for disability and mortality in neurology. This is es-
pecially true in Bulgaria, where vascular diseases in general, and cerebrovascular disease (CVD) in particular, 
are significantly more prevalent than in other European countries. More than 80’000 cases of CVD are reg-
istered yearly in Bulgaria, over 35’000 having stroke (1). Speaking of stroke, we should not underestimate the 
other manifestations of CVD, such as transient ischemic attacks and vascular cognitive impairment. The dis-
ease may develop silently or cause non-specific complaints for years, and only then become clearly symptom-
atic. For this reason the diagnosis of CVD can be delayed, which usually leads to less successful prophylaxis 
and treatment. 
Many modifiable risk factors for CVD have been identified. Some key risk factors, including arterial 
hypertension, insulin resistance or diabetes, obesity, dyslipidemia, have been included in a common defini-
tion: metabolic syndrome (2,3). With the advances of basic and clinical research, their significance is growing. 
However, even with the availability of numerous drugs, arterial hypertension can be hard to control. Obesity 
has become a global epidemic, so a new term of “globesity” was created, and evidence was gathered that type 
2 diabetes mellitus is a disease of the obese people (4). Different criteria for the diagnosis of metabolic syn-
drome have been proposed. The National Cholesterol Education Program Adult Treatment Panel III (NCEP 
ATP III) criteria require 3 of the following 5 features to be present: elevated waist circumference (abdominal 
obesity), elevated triglycerides (≥1.7 mmol/L), low HDL-C (<1.0 mmol/L in men and <1.3 mmol/L in women), 
blood pressure ≥130 mm Hg systolic or ≥85 mm Hg diastolic, and fasting glucose ≥5.6 mmol/L) (3, 5). Meta-
bolic syndrome leads to systemic inflammation that activates the coagulation system and may cause the for-
mation of pathological thrombi (6). In a large follow-up study Rodrigues et al. (7) found that persons with ei-
ther elevated blood pressure or elevated fasting glucose in the clusters to form a metabolic syndrome had the 
highest risk for incident stroke. 
The relationship of metabolic syndrome and cerebrovascular disease and stroke is a topic in this issue of 
Scripta Scientifica Medica. Dr. Arabadzhieva et al. discuss the problem in two articles, one studying age-re-
lated metabolic disturbances (levels of blood glucose and of serum total cholesterol, triglycerides, HDL- and 
LDL-cholesterol) in adult patients with acute ischemic stroke, and another, dedicated to the disorders of glu-
cose metabolism in a similar group of patients. The authors report commonly elevated blood glucose levels, 
higher in males than in females, as well as some age and gender differences in the parameters of lipid metabo-
lism in acute ischemic stroke patients. The results of these studies once again accentuate on the importance of 
metabolic disturbances for CVD, and on the fact that prophylaxis and management of modifiable risk factors 
can be considered the best approach to reduce the high medical and social burden of this disease.
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